Literature DB >> 3089958

Synthesis of N3-fumaramoyl-L-2,3-diaminopropanoic acid analogues, the irreversible inhibitors of glucosamine synthetase.

R Andruszkiewicz, H Chmara, S Milewski, E Borowski.   

Abstract

Several analogues of N3-fumaramoyl-L-2,3-diaminopropanoic acid were synthesized and evaluated for inhibition of glucosamine-6-phosphate synthetase activity. The syntheses were accomplished by acylation reaction of N2-tert.-butoxycarbonyl-L-2,3-diaminopropanoic acid (Boc-A2pr) or N2-tert.-butoxycarbonyl-L-2,4-diaminobutanoic acid (Boc-A2-bu) with the N-succinimidoyl esters of several derivatives of alpha, beta-unsaturated acids 2a-d followed by deprotection of the Boc groups. The obtained compounds were tested for inhibition of glucosamine synthetase isolated from Salmonella typhimurium and Saccharomyces cerevisiae. The results indicated that among the synthesized compounds, N3-4-methoxyfumaroyl-L-2,3-diaminopropanoic acid (FMDP) was the most powerful inhibitor of glucosamine synthetase.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3089958     DOI: 10.1111/j.1399-3011.1986.tb01041.x

Source DB:  PubMed          Journal:  Int J Pept Protein Res        ISSN: 0367-8377


  4 in total

1.  Mechanism of action of anticandidal dipeptides containing inhibitors of glucosamine-6-phosphate synthase.

Authors:  S Milewski; R Andruszkiewicz; L Kasprzak; J Mazerski; F Mignini; E Borowski
Journal:  Antimicrob Agents Chemother       Date:  1991-01       Impact factor: 5.191

2.  Investigation of the inhibition pathway of glucosamine synthase by N3-(4-methoxyfumaroyl)-L-2,3-diaminopropanoic acid by semiempirical quantum mechanical and molecular mechanics methods.

Authors:  M Tarnowska; S Oldziej; A Liwo; Z Grzonka; E Borowski
Journal:  Eur Biophys J       Date:  1992       Impact factor: 1.733

3.  Inhibitors of glucosamine-6-phosphate synthase as potential antimicrobials or antidiabetics - synthesis and properties.

Authors:  Joanna Stefaniak; Michał G Nowak; Marek Wojciechowski; Sławomir Milewski; Andrzej S Skwarecki
Journal:  J Enzyme Inhib Med Chem       Date:  2022-12       Impact factor: 5.756

4.  Transport Deficiency Is the Molecular Basis of Candida albicans Resistance to Antifungal Oligopeptides.

Authors:  Marta Schielmann; Piotr Szweda; Katarzyna Gucwa; Marcin Kawczyński; Maria J Milewska; Dorota Martynow; Joachim Morschhäuser; Sławomir Milewski
Journal:  Front Microbiol       Date:  2017-11-07       Impact factor: 5.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.